Cardioprotective effects of pharmacological blockade of the mitochondrial calcium uniporter on myocardial ischemia-reperfusion injury

Acta Cirúrgica Brasileira
Francisco Sandro Menezes-RodriguesAfonso Caricati-Neto

Abstract

To evaluate whether the attenuation of mitochondrial Ca2+ overload produced by pharmacological blockade of mitochondrial Ca2+ uniporter (MCU) protects the myocardium against injuries caused by cardiac ischemia and reperfusion (CIR). CIR was induced in adult male Wistar rats (300-350 g) by occlusion of the left anterior descendent coronary artery (10 min), followed by reperfusion (120 min). Rats were treated with different doses of MCU blocker ruthenium red (RuR), administered 5 min before ischemia or reperfusion. In untreated rats, the incidences of ventricular arrhythmias (VA), atrioventricular block (AVB) and the lethality (LET) induced by CIR were 85%, 79% and 70%, respectively. In rats treated with RuR before ischemia, the incidences of VA, AVB and LET were significantly reduced to 62%, 25% and 25%, respectively. In rats treated with RuR after ischemia, the incidences of VA, AVB and LET were significantly reduced to 50%, 25% and 25%, respectively. The significant reduction of the incidence of CIR-induced VA, AVB and LET produced by the treatment with RuR indicates that the attenuation of mitochondrial Ca2+ overload produced by pharmacological blockade of MCU can protect the myocardium against injuries caused by CIR.

References

May 22, 2002·Circulation·Subodh VermaTerrence M Yau
Aug 9, 2003·Journal of the American College of Cardiology·Gan-Xin YanPeter R Kowey
Jan 13, 2004·Journal of Electrocardiology·José M Di Diego, Charles Antzelevitch
Aug 11, 2004·Molecular Aspects of Medicine·Michael R Duchen
Sep 22, 2005·Physiology·Brian O'RourkeMiguel A Aon
Jul 17, 2007·Biochimica Et Biophysica Acta·Andrew P HalestrapIgor Khaliulin
Jan 8, 2008·Cell Calcium·Elena N Dedkova, Lothar A Blatter
Apr 2, 2008·Cell Calcium·Michael R DuchenShmuel Muallem
Oct 28, 2008·Heart, Lung & Circulation·Catherine E HugginsLea M D Delbridge
Dec 3, 2008·Journal of Molecular and Cellular Cardiology·M A Hassan TalukderJay L Zweier
Mar 17, 2009·Journal of Molecular and Cellular Cardiology·Elinor J Griffiths
Jun 30, 2009·American Journal of Physiology. Heart and Circulatory Physiology·Lai-Hua Xie, James N Weiss
Jun 11, 2010·Essays in Biochemistry·Michael R Duchen, Gyorgy Szabadkai
Jul 14, 2010·Cardiovascular Research·David A Brown, Brian O'Rourke
Jun 7, 2011·Biochimica Et Biophysica Acta·Fabio Di LisaElizabeth Murphy
Jul 21, 2011·World Journal of Cardiology·Maria-Giulia PerrelliClaudia Penna
Jun 14, 2013·Proceedings of the National Academy of Sciences of the United States of America·George S B WilliamsW J Lederer
Apr 10, 2014·Free Radical Biology & Medicine·Kai-Chien YangSamuel C Dudley
Jan 16, 2015·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·J G P TavaresS Gomes da Silva
Jul 19, 2018·Acta Cirúrgica Brasileira·Francisco Sandro Menezes-RodriguesAfonso Caricati-Neto

❮ Previous
Next ❯

Citations

Feb 16, 2021·Frontiers in Cell and Developmental Biology·Felipe Salazar-RamírezGerardo García-Rivas

❮ Previous
Next ❯

Software Mentioned

GraphPad
Prism
AqDAnalysis

Related Concepts

Related Feeds

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.